Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A fluorogenic analog of the
PLA
(2) substrate PC, named Dabcyl-BODIPY-PC, or simply
DBPC
, was synthesized with a fluorescence quencher (Dabcyl, 4-[(4-[N,N-dimethylamino]phenyl)azo]benzoic acid) in the sn-1 acyl chain and a BODIPY fluor in the sn-2 acyl chain.
DBPC
was recognized by sPLA(2) from each of the four sources examined (bee venom, human synovial fluid, cobra venom, and bovine pancreas). A dramatic and quantifiable fluorescence enhancement of
DBPC
occurred upon phospholipase digestion both in the presence and absence of excess PC. Both real-time and endpoint assays for
PLA
(2) were sensitive, consistent, and rapid. Thus,
DBPC
can be used as a sensitive fluorogenic probe for in vitro high-throughput screening assays for
PLA
(2) activation and inhibition and would expedite studies of
PLA
(2) in cellular signaling, in vitro screening for drug discovery, and subcellular localization of enzyme activity.
...
PMID:A real-time fluorogenic phospholipase A(2) assay for biochemical and cellular activity measurements. 1214 23
PLA
(phospholipases A) are important mediators of cell signaling, generating bioactive fatty acids and LPLs (lysophospholipids).
PLA
products having different head groups can initiate vastly different types of signaling. Fluorogenic analogues of the PLs (phospholipids) PA (phosphatidic acid), PC (phosphatidylcholine), PE (phosphatidylethanolamine), and PG (phosphatidylglycerol) were synthesized as
PLA
substrates for rapidly determining in real time the influence of head group modifications on cell signaling both in vitro and in cells. Enzyme-assisted remodeling of the sn-2 position of the diacylglyceryl moiety with cobra venom
PLA
2 and transphosphatidylation with a particular PLD (phospholipase D) were central steps in the preparation of these enzymatic probes. The resulting fluorogenic Dabcyl- and BODIPY-containing PL analogues, DBPA,
DBPC
, DBPE, and DBPG, were used in mixed micelle assays to determine
PLA
2 kinetics. Next, the assays were used to determine the X i (50) value of a common
PLA
2 inhibitor. Finally, the head group selectivities of a series of commercially available
PLA
2 enzymes were readily established using the DBPLs (Dabcyl-BODIPY PLs) as substrates.
...
PMID:Fluorogenic phospholipids as head group-selective reporters of phospholipase A activity. 1716 43
Phospholipase A(2) (
PLA
(2)) is one of the main components of bee venom. Here, we identify a venom
PLA
(2) from the bumblebee, Bombus ignitus. Bumblebee venom
PLA
(2) (Bi-
PLA
(2)) cDNA, which was identified by searching B. ignitus venom gland expressed sequence tags, encodes a 180 amino acid protein. Comparison of the genomic sequence with the cDNA sequence revealed the presence of four exons and three introns in the Bi-
PLA
(2) gene. Bi-
PLA
(2) is an 18-kDa glycoprotein. It is expressed in the venom gland, cleaved between the residues Arg44 and Ile45, and then stored in the venom sac. Comparative analysis revealed that the mature Bi-
PLA
(2) (136 amino acids) possesses features consistent with other bee
PLA
(2)s, including ten conserved cysteine residues, as well as a highly conserved Ca(2+)-binding site and active site. Phylogenetic analysis of bee
PLA
(2)s separated the bumblebee and honeybee
PLA
(2) proteins into two groups. The mature Bi-
PLA
(2) purified from the venom of B. ignitus worker bees hydrolyzed
DBPC
, a known substrate of
PLA
(2). Immunofluorescence staining of Bi-
PLA
(2)-treated insect Sf9 cells revealed that Bi-
PLA
(2) binds at the cell membrane and induces apoptotic cell death.
...
PMID:Molecular cloning and characterization of a venom phospholipase A2 from the bumblebee Bombus ignitus. 1953 76